ATE90076T1 - Tetrahydrocarbazole ester. - Google Patents
Tetrahydrocarbazole ester.Info
- Publication number
- ATE90076T1 ATE90076T1 AT87302290T AT87302290T ATE90076T1 AT E90076 T1 ATE90076 T1 AT E90076T1 AT 87302290 T AT87302290 T AT 87302290T AT 87302290 T AT87302290 T AT 87302290T AT E90076 T1 ATE90076 T1 AT E90076T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydrocarbazole
- ester
- dysmenorrhea
- prostaglandin
- angina
- Prior art date
Links
- -1 TETRAHYDROCARBAZOLE ESTER Chemical class 0.000 title 1
- XKLNOVWDVMWTOB-UHFFFAOYSA-N 2,3,4,9-tetrahydro-1h-carbazole Chemical class N1C2=CC=CC=C2C2=C1CCCC2 XKLNOVWDVMWTOB-UHFFFAOYSA-N 0.000 abstract 1
- 206010000234 Abortion spontaneous Diseases 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 1
- 206010013935 Dysmenorrhoea Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 abstract 1
- 206010036600 Premature labour Diseases 0.000 abstract 1
- 208000005392 Spasm Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001120 cytoprotective effect Effects 0.000 abstract 1
- 208000026440 premature labor Diseases 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 208000000995 spontaneous abortion Diseases 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- RZWIIPASKMUIAC-VQTJNVASSA-N thromboxane Chemical compound CCCCCCCC[C@H]1OCCC[C@@H]1CCCCCCC RZWIIPASKMUIAC-VQTJNVASSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA505362 | 1986-03-27 | ||
| EP87302290A EP0239306B1 (de) | 1986-03-27 | 1987-03-18 | Tetrahydrocarbazole Ester |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE90076T1 true ATE90076T1 (de) | 1993-06-15 |
Family
ID=4132762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87302290T ATE90076T1 (de) | 1986-03-27 | 1987-03-18 | Tetrahydrocarbazole ester. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0239306B1 (de) |
| JP (1) | JPS6317861A (de) |
| AT (1) | ATE90076T1 (de) |
| DE (1) | DE3786030T2 (de) |
| DK (1) | DK153987A (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4940719A (en) * | 1986-03-27 | 1990-07-10 | Merck Frosst Canada, Inc. | Tetrahydrocarbazole esters, pharmaceutical compositions and use |
| BR0207297A (pt) | 2001-02-15 | 2005-04-19 | King Pharmaceuticals Inc | Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| BR0214958A (pt) * | 2001-12-14 | 2004-12-28 | Zentaris Gmbh | Derivados de tetraidrocarbazol como ligandos para receptores acoplados à proteìna-g (gpcr) |
| DE10164564B4 (de) | 2001-12-14 | 2007-05-16 | Zentaris Gmbh | Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR) |
| DE102004033902A1 (de) | 2004-07-14 | 2006-02-16 | Zentaris Gmbh | Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's) |
| EP2095818A1 (de) | 2008-02-29 | 2009-09-02 | AEterna Zentaris GmbH | Verwendung von LHRH-Antagonisten in nicht-kastrierenden Dosen |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1144905A (en) | 1965-03-25 | 1969-03-12 | Fisons Pharmaceuticals Ltd | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof |
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3630200A (en) | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
| US3687969A (en) | 1970-06-02 | 1972-08-29 | Sterling Drug Inc | 9-aroyl-1,2,3,4-tetrahydrocarbazole-3,3-dicarboxylic acids |
| US3868387A (en) | 1971-04-15 | 1975-02-25 | Hoffmann La Roche | 1,2,3,4-tetrahydrocarbazole-2-carboxylic acids and their derivatives |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| AR205331A1 (es) | 1972-07-24 | 1976-04-30 | Hoffmann La Roche | Procedimiento para la preparacion de carbazoles |
| US3896145A (en) | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| US4009181A (en) | 1973-01-22 | 1977-02-22 | Hoffmann-La Roche Inc. | Cyclopenta[b]indole-2-carboxylic acids and derivatives thereof |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| DE2337154C2 (de) | 1973-07-18 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue Carbazolderivate |
| US4057640A (en) | 1973-07-18 | 1977-11-08 | Schering Aktiengesellschaft | 5,6,7,8:Tetrahydrocarbazole-1-carboxylic acid derivatives |
| GB1511169A (en) | 1975-08-29 | 1978-05-17 | American Home Prod | Trycyclic acetic acid derivatives |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4325961A (en) | 1977-06-01 | 1982-04-20 | Merck & Co., Inc. | Fluorinated amino acids |
| PT68303A (en) | 1977-07-26 | 1978-08-01 | Merck & Co Inc | Process for the preparation of dibenzo/b,f/thiepin |
| EP0003901B1 (de) | 1978-02-24 | 1981-08-05 | Pfizer Limited | 3-(Imidazol-1-ylalkyl) indole als selektive Thromboxansynthetase Hemmungsmittel, pharmazeutische Zusammensetzungen die diese enthalten und Verfahren zu ihrer Herstellung |
| SE7804231L (sv) | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| JPS55313A (en) | 1978-06-13 | 1980-01-05 | Kissei Pharmaceut Co Ltd | Imidazole derivative |
| IL58849A (en) | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
| DK471479A (da) | 1978-12-13 | 1980-06-14 | Pfizer | Fremgangsmaade til fremstilling af imidazolderivater og salte deraf |
| PH16099A (en) | 1979-03-06 | 1983-06-24 | Yamanouchi Pharma Co Ltd | Guanidinothiazole compounds,process for preparing them and medical composition containing them |
| JPS6056143B2 (ja) | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | アミジン誘導体ならびにその製造法 |
| DK151884C (da) | 1979-03-07 | 1988-06-13 | Pfizer | Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf |
| GB2058785B (en) | 1979-09-05 | 1983-05-25 | Glaxo Group Ltd | Phenol derivatives |
| US4237160A (en) | 1979-11-27 | 1980-12-02 | Merck Sharp & Dohme (I.A.) Corp. | 3-Hydroxymethyldibenzo[b,f]thiepins as prostaglandin antagonists |
| EP0040696B1 (de) | 1980-04-30 | 1986-08-27 | Merck & Co. Inc. | Aminothiadiazole als gastrische Inhibitoren |
| US4394508A (en) | 1980-06-07 | 1983-07-19 | Bristol-Myers Company | Chemical compounds |
| DE3169761D1 (en) | 1981-01-09 | 1985-05-09 | Fisons Plc | Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them |
| EP0061800B1 (de) | 1981-03-24 | 1985-08-28 | FISONS plc | Anti-SRS-A-Carbonsäurederivate, Verfahren zu deren Herstellung und pharmazeutische Formulierungen, die jene enthalten |
| US4444775A (en) | 1981-06-22 | 1984-04-24 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridines |
| US4495357A (en) | 1981-07-01 | 1985-01-22 | The Upjohn Company | Pyridyl-substituted-benzofurans |
| DE3373467D1 (en) | 1982-06-14 | 1987-10-15 | Takeda Chemical Industries Ltd | Vinyl carboxylic acid derivatives, their production and use |
| IL69691A (en) | 1982-09-23 | 1988-01-31 | Merck Frosst Canada Inc | Leukotriene antagonists,their preparation and pharmaceutical compositions containing them |
| EP0106565B1 (de) | 1982-09-30 | 1986-09-10 | Merck Frosst Canada Inc. | Leukotrienantagonisten, deren Herstellung und diese enthaltende Zusammensetzungen |
| NZ206795A (en) | 1983-01-21 | 1987-08-31 | Merck Frosst Canada Inc | Phenothiazines, analogues and pharmaceutical compositions |
| EP0138481B1 (de) | 1983-10-05 | 1991-06-26 | Merck Frosst Canada Inc. | Inhibitoren für die Leukotrien-Biosynthese |
| DE3479397D1 (en) | 1983-10-05 | 1989-09-21 | Merck Frosst Canada Inc | Benzoûa¨phenothiazines and hydro-derivatives and pharmaceutical compositions containing them |
| ES8602818A1 (es) | 1983-10-31 | 1985-12-01 | Merck Frosst Canada Inc | Una composicion farmaceutica |
| US4558037A (en) | 1984-06-04 | 1985-12-10 | Merck & Co., Inc. | Cardiovascular composition |
| US4616028A (en) * | 1985-04-22 | 1986-10-07 | American Home Products Corporation | Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use |
| IL81325A (en) * | 1986-01-23 | 1990-11-29 | Merck Frosst Canada Inc | Tetrahydrocarbazole 1-alkanoic acids and pharmaceutical compositions containing them |
-
1987
- 1987-03-18 AT AT87302290T patent/ATE90076T1/de active
- 1987-03-18 EP EP87302290A patent/EP0239306B1/de not_active Expired - Lifetime
- 1987-03-18 DE DE87302290T patent/DE3786030T2/de not_active Expired - Fee Related
- 1987-03-26 DK DK153987A patent/DK153987A/da not_active IP Right Cessation
- 1987-03-27 JP JP62071951A patent/JPS6317861A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0239306B1 (de) | 1993-06-02 |
| DE3786030D1 (de) | 1993-07-08 |
| DE3786030T2 (de) | 1993-12-02 |
| EP0239306A3 (en) | 1989-02-08 |
| JPS6317861A (ja) | 1988-01-25 |
| DK153987A (da) | 1987-09-28 |
| DK153987D0 (da) | 1987-03-26 |
| EP0239306A2 (de) | 1987-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0300676A3 (de) | Tetrahydrocarbazol-1-alkancarbonsäuren | |
| ATE61047T1 (de) | Tetrahydrocarbazol-1-alkansaeuren. | |
| ATE73770T1 (de) | 3-hetero-substituierte n-benzyl-indole. | |
| FI904132A0 (fi) | (kinolin-2-ylmetoxi) indoler som inhibitorer av leukotrieners biosyntes. | |
| ES2087456T3 (es) | (biciclo-hetero-arilmetoxi)indoles como inhibidores de la biosintesis de leucotrienos. | |
| ATE82499T1 (de) | Okulare hypotensivagenzien. | |
| CA2079374A1 (en) | (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis | |
| EP0310179A3 (de) | Tetrahydrocarbazol-Ester | |
| NO870403L (no) | Fremgangsmaate for aa forbedre styrken for finer. | |
| DE3786030D1 (de) | Tetrahydrocarbazole ester. | |
| FI892051A0 (fi) | Foerfarande foer framstaellning av 5-klor-3-klorsulfonyl-2-tiofencarbonsyraestrar. | |
| ATE41740T1 (de) | Verfahren zur retardierung von vitamin c und e. | |
| DE3582365D1 (de) | Material fuer die produktion von normalparaffinen. | |
| CA2007786A1 (en) | Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase | |
| CA2012137A1 (en) | Dibenzoheterocyclic hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase | |
| FI861730A0 (fi) | Foerfarande foer framstaellning av 5,6-dihydroimidazo/4,5,1-j-k//1/benzazepin-2,7(1h,4h)-dion. |